Short Interest in Hypera S.A. (OTCMKTS:HYPMY) Decreases By 50.0%

Hypera S.A. (OTCMKTS:HYPMYGet Rating) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 7,300 shares, a drop of 50.0% from the March 15th total of 14,600 shares. Based on an average daily volume of 116,500 shares, the short-interest ratio is currently 0.1 days.

HYPMY traded down $0.24 during trading hours on Friday, reaching $8.21. 1,607 shares of the stock traded hands, compared to its average volume of 39,337. The firm’s fifty day simple moving average is $7.09 and its two-hundred day simple moving average is $5.86. The company has a market cap of $5.20 billion, a price-to-earnings ratio of 19.56 and a beta of 0.78. Hypera has a fifty-two week low of $4.63 and a fifty-two week high of $8.65.

About Hypera (Get Rating)

Hypera SA operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands.

See Also

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.